March 28, 2018: Imugene Limited (ASX:IMU), an immuno-oncology company is pleased to announce that Ms Leslie Chong has been appointed as Managing Director of the Company, effective immediately.
Immugene Executive Chairman, Mr Paul Hopper, said:
“Since her appointment as CEO, Leslie has led Imugene in an outstanding fashion. Through her leadership and tireless contribution, Imugene has successfully achieved various important milestones in both the clinical and corporate fronts. Her appointment as the company’s Managing Director recognises the value of Leslie’s strategic input as the company continues to deploy its business plan and secure sustainable growth”.
For further information please download PDF attached:
Download this document
